Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06571747 · ClinicalTrials.gov registry record · NA

Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement

A NA study of Cardiovascular Diseases and Influenza, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
3,668,428
Enrollment target
2
Study locations

NCT06571747: Active NA study of Cardiovascular Diseases and Influenza, sponsored by Kaiser Permanente.

NCT06571747 is a NA study of Cardiovascular Diseases and Influenza that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 3,668,428 participants, above the 14,746-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (24777% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06571747, a NA study of Cardiovascular Diseases and Influenza, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3,668,428 participants
Enrollment target
2
Study locations

Study Summary

In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed. KP VACCINATE is a multicenter, sequential, individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs. usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Mid Atlantic States (KPMAS) eligible members during the 2024-2025 influenza season.

Primary Outcome

Proportion of participants with documented influenza vaccine receipt after randomization.

Interventions

  • BEHAVIORAL Cardiovascular-Focused Nudge Communication

Study Locations (2)

California

  • Kaiser Permanente Northern California - Pleasanton

Maryland

  • Kaiser Permanente Mid Atlantic States - Bethesda

Trial Details

FieldValue
Enrollment Target 3,668,428 participants
Start Date 2024-09-05
Est. Completion 2026-03-31
Phase NA
Kaiser Permanente

294 total trials

What the registry record for NCT06571747 still lists

NCT06571747 is an interventional study that assigns participants to a tested intervention. Its 3,668,428 participants enrollment target places it among the larger protocols in the corpus, above the 14,746-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (24777% higher).

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Cardiovascular-Focused Nudge Communication is the first listed.

NCT06571747 reports a single indexed study location in California, Maryland.

Frequently Asked Questions

What is clinical trial NCT06571747 about?

NCT06571747 is a clinical study titled "Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement". In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccinat...

What is the current status of trial NCT06571747?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,668,428 participants. The study started on 2024-09-05. Estimated completion is 2026-03-31.

What conditions does trial NCT06571747 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Influenza, Behavior, Social.

What interventions are being tested in trial NCT06571747?

The interventions under investigation include: Cardiovascular-Focused Nudge Communication (BEHAVIORAL).

Who is sponsoring clinical trial NCT06571747?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06571747 being conducted?

This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06571747's enrollment target sits among peer trials

3,668,428 1st of 300 higher than 300 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02693223 · 3,892,063 participants

    Get With the Guidelines-Stroke Registry

  • NCT06803498 · 3,000,000 participants

    Delivery Room Intervention and Evaluation Network

  • NCT06057181 · 2,000,000 participants

    Helix Research Network

  • NCT07022951 · 1,200,000 participants

    The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06571747, the US trial registry maintained by the National Library of Medicine. NCT06571747 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.